Chiba, Urayasu, Japan Clinical Trials

A listing of Chiba, Urayasu, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 23 clinical trials
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

St.Luke's International Hospital /ID# 213392
 (7.0 away) Contact site
  • 02 Feb, 2021
  • +286 other locations
Special Drug Use Surveillance for Entresto Tablets

This is a single arm, multicenter, observational study in Japanese chronic heart failure patients.

Novartis Investigative Site
 (6.3 away) Contact site
  • 14 Apr, 2021
  • +26 other locations
Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation

The purpose of this study is to clarify the relationship bone marrow-derived cells and the formation of the tumors, and the role of these cells in regeneration of epithelial cells in the gastrointestinal tract.

Cancer and Infection Disease Center, Komagome
 (9.7 away) Contact site
  • 07 Nov, 2020
  • 1 location
Amplatzer PFO Occluder Post-marketing Surveillance Study

The purpose of the Amplatzer PFO Occluder post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of …

Abbott Medical Japan LLC
 (8.9 away) Contact site
  • 29 Apr, 2021
  • 1 location
Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as the Churg-Strauss syndrome, is a systemic necrotizing vasculitis that affects small and medium sized blood vessels. NUCALA (mepolizumab 300 milligrams [mg], subcutaneous administration) was approved in Japan in 2018 for the treatment of EGPA in adult participants. This is a single-arm, multi-center, …

GSK Investigational Site
 (7.4 away) Contact site
  • 14 Jun, 2021
  • +14 other locations
Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

This is a multicenter, uncontrolled, open-label, special drug use study to investigate the safety and efficacy of Xolair by collecting data in its clinical setting in patients with severe to most severe seasonal allergic rhinitis aged 12 years and < 18 years whose symptoms were inadequately controlled despite to conventional …

Novartis Investigative Site
 (1.9 away) Contact site
  • 24 May, 2021
  • +14 other locations
All-Case Surveillance of Ofev in Patients With IPF in Japan

This is a non-interventional study based on new data collection to gather real-world information (i.e., data under routine medical practice) on safety and effectiveness of the Ofev Capsules treatment. The study will consist of a baseline visit and follow-up visits at Week 4, 13, 26, 39, 52, 65, 78, 91 …

 (7.2 away) Contact site
  • 16 Jun, 2021
  • 1 location
Special Investigation of COMIRNATY in the Population With Underlying Diseases

Post-marketing study, Cohort study of COMIRNATY vaccines. To collect information on adverse events and COVID-19 observed after vaccination with COMIRNATY and to assess safety in patients with underlying disease considered to be at high risk of aggravation of COVID-19 who have received vaccination with this product under actual use conditions.

Pfizer Local County
 (7.7 away) Contact site
  • 16 Jun, 2021
  • 1 location
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients Who Have Been Diagnosed With Hemophilia A

The aim of the HEM-POWR study is to understand better how Damoctocog alfa pegol (Jivi) is used to treat people with Hemophilia A in day-to-day life, how well the treatment is tolerated and how satisfied patients and physicians are with the treatment.

damoctocog alfa pegol
antihemophilic factor
Many locations
 (7.2 away) Contact site
  • 25 May, 2021
  • +43 other locations
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

The purpose of this non-interventional study is to identify participants with urothelial cancer (UC) and selected fibroblast growth factor receptor (FGFR) aberrations through molecular testing of their archival tumor tissue.

transitional cell carcinoma
growth factor
Mitsui Memorial Hospital
 (7.6 away) Contact site
  • 27 May, 2021
  • +254 other locations